LEADER 03943nam 2201153z- 450 001 9910557585603321 005 20210501 035 $a(CKB)5400000000043792 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/69064 035 $a(oapen)doab69064 035 $a(EXLCZ)995400000000043792 100 $a20202105d2020 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aStroke, Dementia and Atrial Fibrillation 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2020 215 $a1 online resource (212 p.) 311 08$a3-03936-672-6 311 08$a3-03936-673-4 330 $aThe present special issue will lead you to discover the association between cerebrovascular events, cognitive impairment and atrial fibrillation, through update reviews and original articles exploring the pathophysiological mechanisms underpinning this association and describing the latest results in term of stroke prevention in AF. An interesting scientific journey that reflects the recent advances in pharmacological treatments and interventional procedures involving both mind and heart. 606 $aMedicine$2bicssc 610 $aacetylcholinesterase inhibitor 610 $aaneurysmal subarachnoid hemorrhage 610 $aanticoagulant interruption 610 $aanticoagulation 610 $aantioxidant 610 $aatrial 610 $aatrial fibrillation 610 $aatrial fibrillation (AF) 610 $aatrial fibrillation ablation 610 $aatrial high rate episodes 610 $abrain MRI 610 $acardiovascular risk 610 $acardioversion 610 $acatheter ablation 610 $acerebral ischemia 610 $acerebral small vessel disease 610 $achronic obstructive pulmonary disease 610 $acirculating biomarkers 610 $acognitive decline 610 $acognitive impairment 610 $adementia 610 $adiabetes mellitus 610 $adirect oral anticoagulants (DOACs) 610 $aechocardiography 610 $aelectrical cardioversion (EC) 610 $afibrillation 610 $aGLP-1 receptor agonists 610 $aiatrogenic interatrial septum defect 610 $aIL1B 610 $aIL1RN 610 $ainflammation 610 $ainterdisciplinary setting 610 $aintracerebral hemorrhage 610 $aischemic cerebral events 610 $aleft atrial appendage thrombosis 610 $aleft atrial function 610 $amemory loss 610 $ametabolic syndrome 610 $ametformin 610 $amicrobleeds 610 $aminimally invasive mitral valve repair 610 $amolecular docking 610 $an/a 610 $aneuroprotective 610 $aNOACs 610 $anon vitamin K oral anticoagulants 610 $anovel oral anticoagulants 610 $aobesity 610 $aoral anticoagulation 610 $aoral anticoagulation therapy 610 $aoutcome 610 $aparadoxical embolism 610 $aperception 610 $apolymorphism 610 $aprognosis 610 $aprosthetic valve replacement 610 $arhythm control 610 $ascreening 610 $aSGLT-2 inhibitors 610 $astroke 610 $asubclinical atrial fibrillation 610 $asurgical cryoablation 610 $athiazolidinediones 610 $athrombosis 610 $atransesophageal echocardiography 610 $avenous 615 7$aMedicine 700 $aRusso$b Vincenzo$4edt$0191358 702 $aProietti$b Riccardo$4edt 702 $aRusso$b Vincenzo$4oth 702 $aProietti$b Riccardo$4oth 906 $aBOOK 912 $a9910557585603321 996 $aStroke, Dementia and Atrial Fibrillation$93038530 997 $aUNINA